Noor Ul Ain Rehman
Thu, May 14, 2026 astatine 11:52 AM CDT 2 min read
In a abstracted development, Inhibrx Biosciences, Inc. (NASDAQ:INBX) received a standing update from Stifel connected April 22. The steadfast lifted the terms people connected the banal to $300 from $150 and maintained a Buy standing connected the shares.
Inhibrx Biosciences, Inc. (NASDAQ:INBX) is simply a clinical-stage biopharmaceutical institution with a pipeline of caller biologic therapeutic candidates that were developed done proprietary modular macromolecule engineering platforms. The company’s objective pipeline of therapeutic candidates includes INBRX-109 and INBRX-106.
While we admit the imaginable of INBX arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.
READ NEXT: 15 Stocks That Will Make You Rich successful 10 Years AND 12 Best Stocks That Will Always Grow.
Disclosure: None. Follow Insider Monkey connected Google News.

2 days ago
3





English (CA) ·
English (US) ·
Spanish (MX) ·